IP Library Granted Patent US 11,890,450
Granted Patent B2
US 11,890,450 · App. 16/297,408 · Granted Feb 6, 2024

Backflow prevention mechanism for drug delivery device

Inventors: Lawrence Scott Ring (Laguna Beach, CA); Tohid Pirbodaghi (Cambridge, MA); Samin Akbari (Cambridge, MA); Daniel Eduardo Groszmann (Belmont, MA); Mehran Mojarrad (Thousand Oaks, CA); Mark Gordon (Thousand Oaks, CA); Mikhail Tikh (St. Louis Park, MN); Jimmie L. Ward (Golden, CO); Scott R. Gibson (Granada Hills, CA); Sheldon B. Moberg (Thousand Oaks, CA); Joshua Tamsky (Los Angeles, CA); Paul Faucher (Escondido, CA); Jeff Lind (Thousand Oaks, CA)
Assignee: AMGEN INC.
A61M5/16813A61M5/1413A61M5/14248A61M5/158A61M5/16822A61M39/24A61M5/14526A61M5/155A61M2005/1403A61M2005/1406A61M2005/14252A61M2039/244A61M2039/2406A61M2039/248A61M2039/2426A61M2205/3561A61M2205/505A61M2205/7527A61M2205/7536A61M2209/045
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,890,450
App. No.
16/297,408
Granted
Feb 6, 2024
Kind
B2
Abstract

A drug delivery device includes a housing defining a shell and an inner volume, a container, a drive mechanism, a needle assembly, a fluid flow connection, and a backflow prevention mechanism. The container has an inner volume to contain a medicament to be administered to a user. The drive mechanism is at least partially disposed within the housing and exerts a force to urge the medicament out the container. The fluid flow connection is coupled to the container and the needle assembly and allows the medicament to flow from the container to the needle assembly to be administered. The backflow prevention mechanism is associated with at least one of the container, the fluid flow connection, or the needle assembly and includes at least one flow restrictor to restrict a fluid from flowing from the needle assembly to the container.

Claims (38)

1. A drug delivery device comprising:

a housing defining a shell and an inner volume;

a container at least partially disposed within the housing, the container having an inner volume adapted to contain a medicament to be administered to a user;

a drive mechanism at least partially disposed within the housing, the drive mechanism adapted to exert a force to urge the medicament out the container;

a needle assembly at least partially disposed within the housing, the needle assembly adapted to insert a needle or a trocar into the user's skin and to subsequently retract, thereby leaving a cannula within the user's skin for a period of time at least until the drive mechanism urges the medicament out the container;

a fluid flow connection coupled to the container and the needle assembly, the fluid flow connection adapted to allow the medicament to flow from the container to the needle assembly; and

a backflow prevention mechanism disposed within a coupling region between the container and the needle assembly, the backflow prevention mechanism comprising at least one flow restrictor to restrict a fluid from flowing from the cannula to the container, thereby reducing and/or eliminating clot formation during the period of time at least until the drive mechanism urges the medicament from the container to the needle assembly,

wherein the coupling region includes an upstream portion and a downstream portion, the upstream portion having an upstream diameter larger than the flow restrictor and the downstream portion having a downstream diameter smaller than the flow restrictor.

2. The drug delivery device of claim 1 , wherein the at least one flow restrictor comprises a one-way valve.

3. The drug delivery device of claim 2 , wherein the at least one flow restrictor comprises at least one of:

a slit valve;

an umbrella valve;

a ball valve;

a duckbill valve; or

a flap valve.

4. The drug delivery device of claim 1 , wherein the at least one flow restrictor comprises an air exclusion device.

5. The drug delivery device of claim 1 , wherein the backflow prevention mechanism is disposed at a coupling region at which the fluid flow connection is coupled to the needle assembly.

6. The drug delivery device of claim 5 , wherein the coupling region comprises a ball and reservoir receptacle adapted to seal the needle assembly.

7. The drug delivery device of claim 1 , wherein the fluid flow connection is constructed from a flexible tube.

8. The drug delivery device of claim 7 , wherein the flexible tube is constructed from a polymer material.

9. A backflow prevention mechanism for a drug delivery device, the backflow prevention mechanism disposed within a coupling region between a container and the needle assembly, the backflow prevention mechanism comprising at least one flow restrictor to selectively restrict a fluid from flowing from a cannula to the container over an extended period of time after a needle assembly delivers the cannula within a user's skin, thereby reducing and/or eliminating clot formation,

wherein the coupling region includes an upstream portion and a downstream portion, the upstream portion having an upstream diameter larger than the flow restrictor and the downstream portion having a downstream diameter smaller than the flow restrictor.

10. The backflow prevention mechanism of claim 9 , wherein the at least one flow restrictor comprises a one-way valve.

11. The backflow prevention mechanism of claim 9 , wherein the one-way valve comprises at least one of:

a slit valve;

an umbrella valve;

a ball valve;

a duckbill valve; or

a flap valve.

12. The backflow prevention mechanism of claim 9 , wherein the at least one flow restrictor comprises an air exclusion device.

13. A method of preventing backflow in a drug delivery device having a backflow prevention mechanism, the drug delivery device including housing defining a shell and an inner volume and a container at least partially disposed within the inner volume of the housing and being adapted to contain a medicament to be administered to a user, the method comprising:

at least partially disposing a drive mechanism within the housing, the drive mechanism adapted to exert a force to urge the medicament out of the container;

at least partially disposing a needle assembly within the housing, the needle assembly adapted to insert a needle or a trocar into the user's skin and to subsequently retract, thereby leaving a cannula within the user's skin for a period of time at least until the drive mechanism urges the medicament out the container;

coupling a fluid flow connection to the container and the needle assembly to allow the medicament to flow from the container to the needle assembly; and

disposing a backflow prevention mechanism within a coupling region between the container and the needle assembly, the backflow prevention mechanism comprising at least one flow restrictor that restricts a fluid from flowing from the cannula to the container, thereby reducing and/or eliminating clot formation during the period of time at least until the drive mechanism urges the medicament from the container to the needle assembly.

14. The method of claim 13 , wherein associating the at least one backflow prevention mechanism comprises associating a one way valve with the at least one of the container, the fluid flow connection, or the needle assembly.

15. The method of claim 13 , wherein associating the at least one backflow prevention mechanism comprises associating an air exclusion device with the at least one of the container, the fluid flow connection, or the needle assembly.

16. The method of claim 13 , wherein the backflow prevention mechanism is disposed at a coupling region at which the fluid flow connection is coupled to the needle assembly.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2020
From: RING, LAWRENCE SCOTT; PIRBODAGHI, TOHID; AKBARI, SAMIN; GROSZMANN, DANIEL EDUARDO; MOJARRAD, MEHRAN; GORDON, MARK; TIKH, MIKHAIL; WARD, JIMMIE L.; GIBSON, SCOTT R., MR.; MOBERG, SHELDON B.; TAMSKY, JOSHUA; FAUCHER, PAUL; LIND, JEFF
To: AMGEN INC.
Reel/Frame 051992/0531 →
Continuity (2)
Provisional Application 62640934 · Mar 9, 2018
Related Publication 20190275241A1 · Sep 12, 2019